Home/Filings/4/0001209191-18-006927
4//SEC Filing

KELLEY SCOTT 4

Accession 0001209191-18-006927

CIK 0001419600other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:47 PM ET

Size

7.2 KB

Accession

0001209191-18-006927

Insider Transaction Report

Form 4
Period: 2018-02-01
KELLEY SCOTT
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2018-02-01+8,33314,892 total
  • Award

    Stock option (right to buy)

    2018-02-01+33,33333,333 total
    Exercise: $22.31Exp: 2028-01-31Common Stock (33,333 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2018; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following the one year anniversary of January 1, 2018, so that all of the shares subject to the option shall be vested four (4) years after January 1, 2018.

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeother

Related Parties

1
  • filerCIK 0001222950

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:47 PM ET
Size
7.2 KB